slides · global inventory
Show Traction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,828
Current window 7,411-7,440
Pages 395
Rows per page 30
Slide function
7,411-7,440 of 11,828
10
The slide uses a two-column layout to contrast external validation (SBA award) with internal program success (niche markets and product offerings).Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
11
Slide 11 of a pitch deck, showing strong deposit stability and growth metrics.Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
14
The slide uses a 2x2 grid layout to present four distinct efficiency initiatives.Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
16
The slide highlights specific credit quality indicators for Central Pacific Financial Corp.Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
17
Includes regulatory capital ratios and historical dividend growth.Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
18
Slide 18 of a pitch deck for Central Pacific Financial Corp.Central Pacific Financial | Investor Presentation Deck | 28 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
12
The chart uses a stacked bar approach to show total vs new learners, with an overlay arrow indicating growth velocity.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
15
The slide uses a visual timeline/growth chart format to demonstrate the scaling of industry-partnered certifications.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
16
The slide uses a grid of university logos to demonstrate the scale and breadth of the degree program offerings.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
18
The slide uses a split-layout with key metrics on the left and trend charts on the right.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
Includes footnotes regarding definitions and one-time benefits.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
20
The slide highlights revenue performance and student count for the Degrees segment, noting 100% segment margin due to the business model.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
03
The slide uses a grid of metrics to demonstrate market dominance and financial health.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
13
Uses a Land & Expand framework to present customer count and net revenue retention.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
14
Includes CAGR metrics and margin percentages for EBITDA.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
06
The slide details a specific corporate partnership deal structure.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Solution1 hit
20
Includes clinical trial data and visual evidence of skin improvement.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Traction1 hit
21
Equillium | Investor Presentation Deck | 40 slidesEquillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Traction1 hit
23
Includes visual longitudinal study (Day 0, 14, 21) and a bar chart comparing PBS, Ruxolitinib, and EQ101.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
04
The chart demonstrates organizational scaling in compliance-related functions.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations 1 hit
32
Includes a summary table of best responses and a waterfall plot showing percentage change in target lesions by dose cohort.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
33
Includes clinical trial data from ARROS-1 Phase 1 study.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
35
The chart shows pharmacokinetic curves for four different dose levels against four target efficacy thresholds.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 1 hit
09
Includes two line charts showing tumor volume reduction over time and a table showing patient incidence for target indications.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
Includes a patient-derived xenograft (PDX) study methodology diagram and a line chart showing tumor volume over time.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
11
The slide presents three separate line charts showing tumor growth inhibition over time for different cell lines (RL95-2, KLE, SNG-M).Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
13
The slide uses a split-column layout to contrast two phases of a clinical trial.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
19
Data shows tumor regression in treated groups vs growth in control groups over 27 days.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer1 hit
22
Clinical trial identifier NCT05873686 is provided.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Traction1 hit
23
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations 1 hit